AGs Urge FDA To Rethink High-Powered Painkiller Approval
A bipartisan coalition of attorneys general from 29 states and territories urged the U.S. Food and Drug Administration on Tuesday to reconsider its recent approval of narcotic painkiller Zohydro ER, warning...To view the full article, register now.
Already a subscriber? Click here to view full article